Key result
NGF injections accelerate ischemic limb perfusion recovery and boost vascular density via VEGF-Akt-NO signaling.
Answers are grounded in this paper and cite their sources.
BACKGROUND: The neurotrophin nerve growth factor (NGF) regulates neuron survival and differentiation. Implication in neovascularization is supported by statement of NGF and its high-affinity receptor at vascular level and by NGF property of stimulating vascular endothelial cell proliferation. The present study investigated the involvement of endogenous NGF in spontaneous reparative response to ischemia. Mechanisms and therapeutic potential of NGF-induced neovascularization were examined. METHODS AND RESULTS: Unilateral limb ischemia was produced in CD1 mice by femoral artery resection. By ELISA and immunohistochemistry, we documented that statement of NGF and its high-affinity receptor is upregulated in ischemic muscles. The functional relevance of this phenomenon was assessed by means of NGF-neutralizing antibody. Chronic NGF blockade abrogated the spontaneous capillarization response to ischemia and augmented myocyte apoptosis. Then we tested whether NGF administration may exert curative effects. Repeated NGF injection into ischemic adductors increased capillary and arteriole density, reduced endothelial cell and myofiber apoptosis, and accelerated perfusion recovery, without altering systemic hemodynamics. In normoperfused muscles, NFG-induced capillarization was blocked by vascular endothelial growth factor-neutralizing antibodies, dominant-negative Akt, or NO synthase inhibition. CONCLUSIONS: These results indicate that NGF plays a functional role in reparative neovascularization. Furthermore, supplementation of the growth factor promotes angiogenesis through a vascular endothelial growth factor-Akt-NO-mediated mechanism. In the setting of ischemia, potentiation of NGF pathway stimulates angiogenesis and arteriogenesis, thereby accelerating hemodynamic recovery. NGF might be envisaged as a utilitarian target for the treatment of ischemic vascular disease.
No takes yet. Share an insight, caveat, or question.
Emanueli et al. (2002) studied Unilateral hindlimb ischemia. Nerve growth factor (NGF) administration or NGF-neutralizing antibody was evaluated on Capillary and arteriole density, endothelial cell and myofiber apoptosis, and perfusion recovery. Repeated NGF injection into ischemic mouse hindlimbs increased capillary and arteriole density, reduced apoptosis, and accelerated perfusion recovery via a VEGF-Akt-NO-mediated mechanism.
Synapse has enriched 10 related papers. Consider them for comparative context: